scispace - formally typeset
J

Justin K. Huang

Researcher at University of Texas MD Anderson Cancer Center

Publications -  16
Citations -  699

Justin K. Huang is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Cancer & Chromosome instability. The author has an hindex of 10, co-authored 14 publications receiving 489 citations. Previous affiliations of Justin K. Huang include University of California, San Diego.

Papers
More filters
Journal ArticleDOI

Systematic Evaluation of Molecular Networks for Discovery of Disease Genes

TL;DR: This work evaluates 21 human genome-wide interaction networks for their ability to recover 446 disease gene sets identified through literature curation, gene expression profiling, or genome- wide association studies to create a parsimonious composite network with both high efficiency and performance.
Journal ArticleDOI

A global transcriptional network connecting noncoding mutations to changes in tumor gene expression.

TL;DR: An integrative analysis of tumor whole genomes and matched transcriptomes finds that the effects of noncoding mutations on DAAM1, MTG2 and HYI transcription are recapitulated in multiple cancer cell lines and that increasingDAAM1 expression leads to invasive cell migration.
Journal ArticleDOI

Disruption of NSD1 in Head and Neck Cancer Promotes Favorable Chemotherapeutic Responses Linked to Hypomethylation.

TL;DR: This study uses CRISPR-Cas9 to disrupt NSD1 in HNSCC cell lines and finds that this leads to substantial CpG hypomethylation and sensitivity to cisplatin, a standard chemotherapy in head and neck cancer, with a 40% to 50% decrease in the IC50 value.
Journal ArticleDOI

Genomic Landscape of Appendiceal Neoplasms

TL;DR: Epithelial appendiceal cancers and goblet cell carcinoids show differences in KRAS and GNAS mutation frequencies and have mutation profiles distinct from CRC, highlighting the benefit of performing molecular profiling on rare tumors to identify prognostic and predictive biomarkers and new therapeutic targets.